Sai Parenterals reports strong FY26 results with revenue up 140.37% and PAT up 45.52%, driven by CDMO exports and Australian subsidiary integration.

SP

Sai Parenterals LimitedSAIPARENT · Filed with the exchange

Capex of ~₹440 crore for expansion is ongoing.

No comments yet. Be the first.

More from Sai Parenterals Limited

Free

Join 5,000+ investors following the market on Alpha Tribe.

Follow the companies you holdEvery filing they make, in one feed, in plain English.
Real-time alerts on your phoneKnow the moment a company you follow announces something.
Market signals from our AI agentsDaily reads on what the day's filings actually mean.

No card needed. Takes about a minute.